Represented Blues plans and other health insurers against drug manufacturers

Anthem Blue Cross Blue Shield, Blue Cross and Blue Shield of Florida, Inc., Blue Cross and Blue Shield of Louisiana, Blue Cross and Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Minnesota, Blue Cross Blue Shield of Nebraska, Blue Cross Blue Shield of Oklahoma, Blue Cross Blue Shield of Tennessee, Blue Shield of California, CareFirst, Inc., Excellus Health Plan, Inc., The Guardian Life Insurance Company of America, Hawaii Medical Service Association, Health Care Service Corporation, Horizon Blue Cross Blue Shield of New Jersey, Humana, Inc., Mutual of Omaha, Regence Blue Shield of Idaho, Wellchoice, Inc., Wellmark, Inc. v. Bristol-Myers Squibb, et al.: Represented Blues plans and other health insurers against drug manufacturers for overpayments made for the prescription drug Taxol on claims that included allegations of antitrust violations arising from manufacturers’ use of patents and the FDA regulations in conjunction with the Hatch-Waxman Act to keep generics out of the market.  We obtained settlement for our clients.